CareTrust REIT, Inc. (CTRE)
NYSE: CTRE · Real-Time Price · USD
36.55
-0.04 (-0.11%)
At close: Oct 16, 2026, 4:00 PM EDT
36.89
+0.34 (0.92%)
After-hours: Oct 16, 2026, 7:32 PM EDT
CareTrust REIT Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, CareTrust REIT stock has a consensus rating of "Strong Buy" and an average price target of $43.79. The average 1-year stock price forecast is 19.81% higher than the current stock price, while the lowest is $41 (+12.18%) and the highest is $49 (+34.06%).
Price Target: $43.79 (+19.81%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CareTrust REIT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 9 | 10 | 10 | 10 | 10 |
| Buy | 2 | 3 | 3 | 2 | 2 | 2 |
| Hold | 1 | 1 | 0 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 13 | 13 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Hold Initiates $41 | Hold | Initiates | $41 | +12.18% | Oct 16, 2026 |
| UBS | UBS | Buy Reiterates $48 → $44 | Buy | Reiterates | $48 → $44 | +20.38% | Oct 13, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 6, 2026 |
| KeyBanc | KeyBanc | Buy Reiterates $46 | Buy | Reiterates | $46 | +25.85% | Oct 6, 2026 |
| Raymond James | Raymond James | Buy Maintains $45 → $42 | Buy | Maintains | $45 → $42 | +14.91% | Oct 5, 2026 |
Financial Forecast
Revenue This Year
619.67M
from 476.39M
Increased by 30.08%
Revenue Next Year
794.75M
from 619.67M
Increased by 28.25%
EPS This Year
1.69
from 1.36
Increased by 24.19%
EPS Next Year
1.84
from 1.69
Increased by 8.91%
EPS based on non-GAAP adjusted numbers.